News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


Xenova: Interim Results Announcement 2001 (PR Newswire) ... innovative immunotherapeutic vaccine, is designed as a treatment for a broad range of solid tumors.......DISC-GMCSF delivers the gene for the expression of GM-CSF, a potent stimulator of anti-tumor immune responses, direct to the tumor site through the use of a disabled virus vector (DISC)...... the nicotine will bind to these antibodies, which are too large to cross the blood-brain barrier, thus reducing or removing the pleasurable stimulus which usually accompanies smoking.... - Aug 13 6:26 PM ET

IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source:

(Everything below this line is from!)

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557